Quantcast

Latest pharmaceutical industry Stories

2014-08-20 08:28:40

BISHOPS STORTFORD, England, August 20, 2014 /PRNewswire/ -- Dotmatics data analysis and visualisation tool proven essential in Prof. Cooper's team's quest for finding new 'superbug' antibiotics Dotmatics [http://www.dotmatics.com ], a leading provider of scientific informatics solutions and services, announced today that Prof. Cooper's renowned Medicinal Chemistry and Drug Development research group at the Institute for Molecular Bioscience, University of Queensland has...

2014-08-20 08:27:41

ENGLEWOOD, Colo., Aug. 20, 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that in response to requests from patients and physicians, the company has performed an analysis of the available data from both portions of the study. On October 7, 2013, following an IDRC determination "that there was a treatment dosage (of Optina(TM)) that was demonstrating a potentially beneficial anatomic effect." The company initiated an open label extension study using the...

2014-08-19 23:13:32

With more than 50 years of combined experience, expert presenters Sherri Hubby and Brian Nugent will share insights that can be used to establish Risk Based Monitoring Plans, including triggers for return to 100% source data verification. Even better, they'll show attendees how to proactively identify and manage risks to trials with methods that can immediately be implemented and used. Falls Church, VA (PRWEB) August 19, 2014 Managing Risk for Clinical Trials: Incorporating Quality by...

2014-08-19 16:29:38

Alabama Supreme Court decision is an important win for patients in cases involving prescription drugs BIRMINGHAM, Ala., Aug. 19, 2014 /PRNewswire/ -- The Alabama Supreme Court, in a 6-3 decision on August 15, 2014, re-affirmed that patients can sue drug makers who mislead doctors into believing that prescription medicines the companies market do not cause harmful side?effects. The case is Weeks v. Wyeth, and the decision came after the Supreme Court ruled against the drug makers in...

2014-08-19 16:29:08

Funding To Increase Manufacturing Capacity for Ramp-Up of Programs BETHESDA, Md., Aug. 19, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that the $17.5 million convertible note offering announced last Thursday, August 14, 2014, has closed. The three-year notes have a 5% interest rate and are convertible at $7.30 per share of common stock. The...

2014-08-19 08:30:53

MALVERN, Pa., Aug. 19, 2014 /PRNewswire/ -- SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of late-stage pharmaceutical products for the treatment of pain, announced that it had formed a Scientific Advisory Board composed of four members: Dr. Jeff Gudin, Dr. Charles Argoff, Dr. Srinivas Nalamachu and Mr. Kip Vought. SCILEX Chief Executive Officer Anthony Mack said the expertise of this board would greatly assist in the development and...

2014-08-19 08:30:32

GLEN BURNIE, Md., Aug. 19, 2014 /PRNewswire/ -- CSSi, the leader in patient recruitment solutions for the clinical research industry, recently announced the formation of the company's Medical and Clinical Advisory Board ("MCAB") and is pleased to announce the addition of Dr. William E. Gannon, Jr. to the MCAB. Photo - http://photos.prnewswire.com/prnh/20140818/136957 The MCAB, with Dr. Gannon's leadership, will help provide insight across a variety of therapeutic areas and set...

2014-08-19 08:30:18

JERUSALEM, August 19, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Intellectual Property Department of Spain has granted the Company's patent for its invention, titled "Methods and Compositions for Oral Administrations of Proteins." About Oramed Pharmaceuticals Oramed Pharmaceuticals is a...

2014-08-19 08:30:02

BELLEVILLE, ON, Aug. 19, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) today announced that it is targeting Q1/2015 for the filing of a Biologics License Application (BLA) with the United States Food and Drug Administration (FDA) for Bioniche's lead program Mycobacterial Cell Wall-Nucleic Acid Complex (MCNA) for the treatment of patients with high grade non-muscle invasive bladder cancer that have failed Bacillus Calmette-Guérin (BCG) therapy. This projected timeline...

2014-08-19 08:29:01

MUMBAI, August 19, 2014 /PRNewswire/ -- 'Weight Loss- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. While the leading brands, companies and chemicals are...


Word of the Day
monteith
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'
Related